FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 21.60B +11.7% |
| Revenue (ttm) | 6.15B +8.5% |
| Net Income | 1.24B +13.1% |
| EPS | 50.09 +17.1% |
| Shares Out | 24.41M |
| PE Ratio | 17.67 |
| Forward PE | 15.73 |
| Dividend | 27.00 (3.04%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 50,800 |
| Open | 890.00 |
| Previous Close | 889.00 |
| Day's Range | 885.00 - 903.00 |
| 52-Week Range | 717.00 - 1,011.00 |
| Beta | 0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About FINDEX
FINDEX Inc. offers medical devices in Japan. It operates through Medical Business, Public Business, and Healthtech Business segments. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration FAX ref... [Read more]
Financial Performance
In 2025, FINDEX's revenue was 6.11 billion, an increase of 4.59% compared to the previous year's 5.84 billion. Earnings were 1.26 billion, an increase of 8.09%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.